Cargando…
The Efficacy of Probiotics as Antiviral Agents for the Treatment of Rotavirus Gastrointestinal Infections in Children: An Updated Overview of Literature
Enteric viruses, including the rotavirus, norovirus, and adenoviruses, are the most common cause of acute gastroenteritis. The rotavirus disease is especially prevalent among children, and studies over the past decade have revealed complex interactions between rotaviruses and the gut microbiota. One...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781831/ https://www.ncbi.nlm.nih.gov/pubmed/36557645 http://dx.doi.org/10.3390/microorganisms10122392 |
_version_ | 1784857170573000704 |
---|---|
author | Steyer, Andrej Mičetić-Turk, Dušanka Fijan, Sabina |
author_facet | Steyer, Andrej Mičetić-Turk, Dušanka Fijan, Sabina |
author_sort | Steyer, Andrej |
collection | PubMed |
description | Enteric viruses, including the rotavirus, norovirus, and adenoviruses, are the most common cause of acute gastroenteritis. The rotavirus disease is especially prevalent among children, and studies over the past decade have revealed complex interactions between rotaviruses and the gut microbiota. One way to treat and prevent dysbiosis is the use of probiotics as an antiviral agent. This review focuses on the latest scientific evidence on the antiviral properties of probiotics against rotavirus gastroenteric infections in children. A total of 19 studies exhibited a statistically significant antiviral effect of probiotics. The main probiotics that were effective were Saccharomyces cerevisiae var. boulardii, Lacticaseibacillus rhamnosus GG, and various multi-strain probiotics. The underlying mechanism of the probiotics against rotavirus gastroenteric infections in children included immune enhancement and modulation of intestinal microbiota leading to shortening of diarrhoea. However, several clinical studies also found no significant difference in the probiotic group compared to the placebo group even though well-known strains were used, thus showing the importance of correct dosage, duration of treatment, quality of probiotics and the possible influence of other factors, such as the production process of probiotics and the influence of immunisation on the effect of probiotics. Therefore, more robust, well-designed clinical studies addressing all factors are warranted. |
format | Online Article Text |
id | pubmed-9781831 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97818312022-12-24 The Efficacy of Probiotics as Antiviral Agents for the Treatment of Rotavirus Gastrointestinal Infections in Children: An Updated Overview of Literature Steyer, Andrej Mičetić-Turk, Dušanka Fijan, Sabina Microorganisms Review Enteric viruses, including the rotavirus, norovirus, and adenoviruses, are the most common cause of acute gastroenteritis. The rotavirus disease is especially prevalent among children, and studies over the past decade have revealed complex interactions between rotaviruses and the gut microbiota. One way to treat and prevent dysbiosis is the use of probiotics as an antiviral agent. This review focuses on the latest scientific evidence on the antiviral properties of probiotics against rotavirus gastroenteric infections in children. A total of 19 studies exhibited a statistically significant antiviral effect of probiotics. The main probiotics that were effective were Saccharomyces cerevisiae var. boulardii, Lacticaseibacillus rhamnosus GG, and various multi-strain probiotics. The underlying mechanism of the probiotics against rotavirus gastroenteric infections in children included immune enhancement and modulation of intestinal microbiota leading to shortening of diarrhoea. However, several clinical studies also found no significant difference in the probiotic group compared to the placebo group even though well-known strains were used, thus showing the importance of correct dosage, duration of treatment, quality of probiotics and the possible influence of other factors, such as the production process of probiotics and the influence of immunisation on the effect of probiotics. Therefore, more robust, well-designed clinical studies addressing all factors are warranted. MDPI 2022-12-02 /pmc/articles/PMC9781831/ /pubmed/36557645 http://dx.doi.org/10.3390/microorganisms10122392 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Steyer, Andrej Mičetić-Turk, Dušanka Fijan, Sabina The Efficacy of Probiotics as Antiviral Agents for the Treatment of Rotavirus Gastrointestinal Infections in Children: An Updated Overview of Literature |
title | The Efficacy of Probiotics as Antiviral Agents for the Treatment of Rotavirus Gastrointestinal Infections in Children: An Updated Overview of Literature |
title_full | The Efficacy of Probiotics as Antiviral Agents for the Treatment of Rotavirus Gastrointestinal Infections in Children: An Updated Overview of Literature |
title_fullStr | The Efficacy of Probiotics as Antiviral Agents for the Treatment of Rotavirus Gastrointestinal Infections in Children: An Updated Overview of Literature |
title_full_unstemmed | The Efficacy of Probiotics as Antiviral Agents for the Treatment of Rotavirus Gastrointestinal Infections in Children: An Updated Overview of Literature |
title_short | The Efficacy of Probiotics as Antiviral Agents for the Treatment of Rotavirus Gastrointestinal Infections in Children: An Updated Overview of Literature |
title_sort | efficacy of probiotics as antiviral agents for the treatment of rotavirus gastrointestinal infections in children: an updated overview of literature |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781831/ https://www.ncbi.nlm.nih.gov/pubmed/36557645 http://dx.doi.org/10.3390/microorganisms10122392 |
work_keys_str_mv | AT steyerandrej theefficacyofprobioticsasantiviralagentsforthetreatmentofrotavirusgastrointestinalinfectionsinchildrenanupdatedoverviewofliterature AT miceticturkdusanka theefficacyofprobioticsasantiviralagentsforthetreatmentofrotavirusgastrointestinalinfectionsinchildrenanupdatedoverviewofliterature AT fijansabina theefficacyofprobioticsasantiviralagentsforthetreatmentofrotavirusgastrointestinalinfectionsinchildrenanupdatedoverviewofliterature AT steyerandrej efficacyofprobioticsasantiviralagentsforthetreatmentofrotavirusgastrointestinalinfectionsinchildrenanupdatedoverviewofliterature AT miceticturkdusanka efficacyofprobioticsasantiviralagentsforthetreatmentofrotavirusgastrointestinalinfectionsinchildrenanupdatedoverviewofliterature AT fijansabina efficacyofprobioticsasantiviralagentsforthetreatmentofrotavirusgastrointestinalinfectionsinchildrenanupdatedoverviewofliterature |